Aimed Alliance
Navigate
  • Home
  • About
    • Mission, Vision, Beliefs
    • Staff
    • Board of Directors
    • Aimed Alliance Supporters
    • Annual Reports
    • Privacy Policy
  • Policy Priorities
  • Initiatives
    • Alternative Funding Programs
    • Copay Accumulator 101
    • Judicial Advocacy
    • Know Your Rights
    • Step Therapy
      • New York Step Therapy Reform
      • Arizona Access First Alliance
    • Prescription Drug Affordability Boards
  • Resources
    • All
    • Stakeholders
    • Aimed in the News
    • Health News & Lawsuits
    • Newsletters & Media
  • Maps
    • Bad Drug Ads
      • Active Legislation
      • Enacted Laws
    • Copay Accumulators
      • Active Legislation
      • Enacted Laws
    • Nonmedical Switching
      • Active Legislation
      • Enacted Laws
    • Prior Authorization
      • Active Legislation
      • Enacted Laws
    • Step Therapy
      • Active Legislation
      • Enacted Laws
    • Biomarker Testing
      • Active Legislation
      • Enacted Laws
    • Oral Parity
      • Enacted Laws
  • Events
  • Contact

Aimed Alliance Responds to HHS’s Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs

0
By Aimed Alliance on July 17, 2018 Aimed Activity, Comments & Sign-on Letters, Drug Pricing, Drug Pricing: Policy Activity, Policymakers, Resources

Aimed Alliance Responds to HHS’s Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Read here.

Last Updated on May 13, 2020 by Aimed Alliance

Advocacy FDA Federal Medicare Pharmacy Benefit Managers Rebates Transparency
Share. Twitter Facebook Pinterest LinkedIn Tumblr Email

Related Posts

  • February 19, 2026

    GLOBE Model Expected to Have Minimal Impact on Part B OOP Costs  

  • February 11, 2026

    New Report – International Reference Pricing: Lessons Learned from Abroad

  • February 2, 2026

    Aimed Alliance Urges Reconsideration of VA PDAB Bill

Comments are closed.

  • Aimed Alliance

  • Aimed Alliance is a 501 (c)(3) not-for-profit health policy organization that protects and enhances the rights of health care consumers and professionals.

    • Twitter
    • Facebook
    • Instagram
    • LinkedIn
    • YouTube